Yuan Xu
Director/Board Member at AKERO THERAPEUTICS, INC.
Net worth: - $ as of 30/03/2024
Profile
Yuan J.
Xu is an Independent Director at Fate Therapeutics, Xilio Therapeutics, and Akero Therapeutics.
Previously, Xu served as the Chief Executive Officer & Director at Legend Biotech Corp., General Manager & Vice President-Biologics at Gilead Sciences, Senior Vice President at Merck & Co., and Vice President at Novartis AG.
Xu holds a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LEGEND BIOTECH CORP.
-.--% | 07/06/2020 | 0 ( -.--% ) | - $ | 30/03/2024 |
Yuan Xu active positions
Companies | Position | Start |
---|---|---|
AKERO THERAPEUTICS, INC. | Director/Board Member | 21/04/2021 |
FATE THERAPEUTICS, INC. | Director/Board Member | 02/08/2021 |
XILIO THERAPEUTICS, INC. | Director/Board Member | 03/01/2022 |
Former positions of Yuan Xu
Companies | Position | End |
---|---|---|
LEGEND BIOTECH CORPORATION | Chief Executive Officer | 31/07/2020 |
MERCK & CO., INC. | Corporate Officer/Principal | 31/07/2017 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 31/07/2015 |
NOVARTIS AG | Corporate Officer/Principal | 31/12/2013 |
Training of Yuan Xu
University of Maryland | Doctorate Degree |
Nanjing University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
NOVARTIS AG | Health Technology |
FATE THERAPEUTICS, INC. | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Yuan Xu